195 related articles for article (PubMed ID: 11363396)
1. Saquinavir (Invirase).
Treat Rev; 1996 Apr; (no 21):5. PubMed ID: 11363396
[TBL] [Abstract][Full Text] [Related]
2. No tease this time--pros and cons of a long-awaited anti-HIV drug.
Chang HE
Posit Aware; 1996; 7(1):18-20. PubMed ID: 11363118
[TBL] [Abstract][Full Text] [Related]
3. Roche submits NDA for Invirase.
J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):37-8. PubMed ID: 11362796
[TBL] [Abstract][Full Text] [Related]
4. Saquinavir (Invirase): first protease inhibitor approved--reimbursement, information hotline numbers.
James JS
AIDS Treat News; 1995 Dec; (no 237):1-2. PubMed ID: 11363073
[TBL] [Abstract][Full Text] [Related]
5. Saquinavir gets accelerated approval.
McGuire S
Posit Aware; 1996; 7(1):8. PubMed ID: 11363135
[TBL] [Abstract][Full Text] [Related]
6. FDA approves 3TC and saquinavir. Food and Drug Administration.
Baker R
BETA; 1995 Dec; ():5, 9. PubMed ID: 11363011
[TBL] [Abstract][Full Text] [Related]
7. A kinder, gentler ddC... for $7,200 a year.
GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362996
[TBL] [Abstract][Full Text] [Related]
8. New drugs for HIV infection.
Med Lett Drugs Ther; 1996 Apr; 38(972):35-7. PubMed ID: 8606677
[TBL] [Abstract][Full Text] [Related]
9. Saquinavir with grapefruit juice.
Posit Aware; 1996; 7(1):5. PubMed ID: 11363122
[TBL] [Abstract][Full Text] [Related]
10. Potent new AIDS drugs underscore promise of combination therapy.
AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
[TBL] [Abstract][Full Text] [Related]
11. Lottery opens 2,000 slots for protease trial.
AIDS Alert; 1995 Nov; 10(11):144. PubMed ID: 11362929
[TBL] [Abstract][Full Text] [Related]
12. Update on HIV protease inhibitors.
Vella S
AIDS Clin Care; 1995 Oct; 7(10):79-82, 88. PubMed ID: 11362832
[TBL] [Abstract][Full Text] [Related]
13. 3TC and saquinavir: we need them now.
Baker R
BETA; 1995 Sep; ():3. PubMed ID: 11362889
[TBL] [Abstract][Full Text] [Related]
14. Saquinavir: combination shows survival benefit; new formulation trial recruiting.
AIDS Treat News; 1996 May; (no 246):1-2. PubMed ID: 11363484
[TBL] [Abstract][Full Text] [Related]
15. Saquinavir (Roche protease inhibitor) at higher doses.
AIDS Treat News; 1995 Sep; (no 231):5. PubMed ID: 11362870
[TBL] [Abstract][Full Text] [Related]
16. Ritonavir: first to prolong survival.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):38-44. PubMed ID: 11363517
[TBL] [Abstract][Full Text] [Related]
17. FDA antiviral advisory hearings on lamivudine (Epivir, 3TC), saquinavir (Invirase), stavudine (Zerit, d4T), November 6-8. Food and Drug Administration.
AIDS Treat News; 1995 Oct; (no 233):4-5. PubMed ID: 11363038
[TBL] [Abstract][Full Text] [Related]
18. Protease inhibitor: Roche lottery deadline July 21.
AIDS Treat News; 1995 Jul; (no 226):4-5. PubMed ID: 11362614
[TBL] [Abstract][Full Text] [Related]
19. [Which is the strategy? The latest in the use of antiretrovirals].
Agosto M
Sidahora; 1995; ():33-4. PubMed ID: 11363205
[TBL] [Abstract][Full Text] [Related]
20. Saquinavir thwarts resistance.
AIDS Alert; 1995 Oct; 10(10):123. PubMed ID: 11362782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
